Clinical Trial Applications: Filter, Search, and view applications
| # | Protocol No | Study Title | Investigator(s) & Site(s) | |
|---|---|---|---|---|
26. |
ECCT/22/12/01 | HIV & Tobacco Cessation Study Integrating Tobacco use cessation into HIV care and Treatment Clinics in Ministry of Health Facilities in Kisumu County, Kenya |
Principal Investigator(s) 1. Elizabeth Bukusi Site(s) in Kenya KEMRI-RCTP |
View |
27. |
ECCT/12/04/01 | A double-masked randomised placebo-controlled trial of adjuvant topical 5-fluorouracil (5FU) treatment following surgical excision of ocular surface squamous neoplasia. |
Principal Investigator(s) 1. Stephen Gichuhi Site(s) in Kenya 1. Kenyatta National Hospital (Nairobi City county) 2. PCEA Kikuyu Eye Unit (Kiambu county) 3. Sabatia Eye Hospital (Kakamega county) 4. Kitale District Hospital, Eye Unit (Trans Nzoia county) 5. Homa Bay District Hospital, Eye Unit (Homa Bay county) |
View |
28. |
ECCT/21/12/04 | FAST Study Assessments of the EFficacy, the onset-of-Action and the Safety of Tot'héma® in adults with moderate iron deficiency anaemia |
Principal Investigator(s) 1. Dr. Francis Xavier Otieno Odawa Site(s) in Kenya 1. MOI University Teaching and Referral Hospital (Nandi county) 2. UNIM Research and Training Centre (Kisumu county) 3. Kenyatta National Hospital (Nairobi City county) |
View |
29. |
ECCT/19/11/04 | Second line switch to Dolutegravir (2SD) study Switching Treatment-Experienced, Integrase Inhibitor-Naïve, Virally Suppressed HIV-1 Infected Adults from Ritonavir boosted Protease Inhibitors to Dolutegravir: An Open-Label Randomized Controlled Trial |
Principal Investigator(s) 1. Loice Achieng Site(s) in Kenya 1. Kenyatta National Hospital (Nairobi City county) 2. Jaramogi Oginga Odinga Teaching and Referral Hospital (Kisumu county) 3. Thika Level 5 Hospital (Kiambu county) 4. Kiambu Level 5 Hospital (Kiambu county) |
View |
30. |
ECCT/15/01/02 | Study title An observational pilot study to characterize the immune response induced by the commercial Varicella Zoster Virus vaccine Zostavax® (Merck) in healthy adult females in Nairobi, Kenya. Clinical Phase IV |
Principal Investigator(s) 1. Prof Walter Jaoko Jaoko Site(s) in Kenya KAVI-INSTITUTE OF CLINICAL RESEARCH (KAVI-ICR) |
View |